4//SEC Filing
Aberdare Management Company, LLC 4
Accession 0001209191-18-039666
CIK 0001645666other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:45 PM ET
Size
11.3 KB
Accession
0001209191-18-039666
Insider Transaction Report
Form 4
Aberdare Management Company, LLC
10% Owner
Transactions
- Conversion
Series B Convertible Preferred Stock
2018-06-25−31,481→ 0 total→ Common Stock (31,481 underlying) - Conversion
Common Stock
2018-06-25+105,162→ 105,162 total - Conversion
Common Stock
2018-06-25+31,481→ 136,643 total - Conversion
Series A Convertible Preferred Stock
2018-06-25−105,162→ 0 total→ Common Stock (105,162 underlying)
Footnotes (2)
- [F1]Each share of Series A Convertible Preferred Stock and Series B Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock upon the closing of the Issuer's initial public offering.
- [F2]The members of Aberdare Management Company, LLC are Paul H. Klingenstein and Kathleen R. Bole.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001744257
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:45 PM ET
- Size
- 11.3 KB